Sign in

CIK 0001094038

  • Non-accelerated filer
  • Smaller reporting company

Marker Therapeutics, Inc.

Sign in to watch
Ticker
MRKR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880277072
Phone
+1 713-400-6400
Business address
2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
Former names
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 58 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-27 Koneru Mythili Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +51,918 51,918
2023-02-27 Loiacono Michael Chief Accounting Officer Grant or award · Employee Stock Option (right to buy) +38,480 38,480
2023-02-27 Vera Juan Chief Scientific Officer & COO Grant or award · Employee Stock Option (right to buy) +46,487 46,487
2023-02-27 Szymanska Anna Vice President, Quality Grant or award · Employee Stock Option (right to buy) +29,947 29,947
2023-02-27 Agopyan Nadia SVP, Regulatory Affairs Grant or award · Employee Stock Option (right to buy) +34,154 34,154
2022-05-24 Wilson John Robert Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2022-05-24 Laskow-Pooley David Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2022-05-24 Knobil Katharine Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2022-05-24 ELMS STEVE Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2022-05-24 Eansor Norman David Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2022-03-24 Hoang Peter L. President and CEO Grant or award +199,094 531,662
2022-03-24 Hoang Peter L. President and CEO Shares withheld for taxes −48,376 $0.48 $23K 483,286
2022-03-24 Vera Juan Chief Scientific Officer & COO Grant or award +140,823 2,705,310
2022-03-24 Vera Juan Chief Scientific Officer & COO Shares withheld for taxes −33,465 $0.48 $16K 2,671,845
2022-03-24 Kim Anthony H. Chief Financial Officer Grant or award +150,512 150,512
2022-03-24 Kim Anthony H. Chief Financial Officer Shares withheld for taxes −36,076 $0.48 $17K 114,436
2022-02-17 Hoang Peter L. President and CEO Grant or award · Employee Stock Option (right to buy) +430,000 430,000
2022-02-17 Vera Juan Chief Scientific Officer & COO Grant or award · Employee Stock Option (right to buy) +160,000 160,000
2022-02-17 Szymanska Anna Vice President, Quality Grant or award · Employee Stock Option (right to buy) +40,000 40,000
2022-02-17 Loiacono Michael Chief Accounting Officer Grant or award · Employee Stock Option (right to buy) +140,000 140,000

Page 2 of 6 · 119 trades